Labiotech.eu

News and Trends 21 Nov 2015

What happened this week? Genfit, History of Biotech, Cellectis

Monday: Interview with the CEO of Genfit – The Billion Euro Liver Biotech on its phase III NASH Drug Tuesday: History of Biotech: How Modern Biotechnology Started-Up 39 Years Ago Wednesday: The UK Catapults Cell Therapy Manufacture into Europe with a €78.5M New Facility Thursday: Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas […]

November 21, 2015 - 1 minutemin - By Philip Hemme

News and Trends 20 Nov 2015

Get to Know the Top 50 Women in the UK’s Biotech Scene

The Movers & Shakers Report 2015 lists 50 of the Top female Bio-Entrepreneurs… here’s a select few I found particularly impressive in the Biotech Industry! Written by Miranda Weston-Smith, the BioBeat15 report is sponsored by Horton Ruston Poole, Johnson & Johnson Innovation, MedImmune and Pfizer to celebrate what women working in bio-business have brought to […]

November 20, 2015 - 5 minutesmins - By Dani Bancroft

News and Trends 20 Nov 2015

Cinfa Biotech’s Biosimilar is on the Starting Block!

Recently launched Cinfa Biotech just treated the first subjects in a clinical trial with its biosimilar of Neulasta®! Cinfa Biotech just announced that the first subjects have been dosed in a clinical trial of B12019, a biosimilar version of Amgen’s Neulasta® (pegfilgrastim) to treat chemotherapy-induced neutropenia. Though chemotherapy is highly effective against cancer, it is […]

November 20, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 20 Nov 2015

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

This week we say farewell to Austria and head North-West, across the United Kingdom and land in the Emerald Isle, Ireland, where we arrive at our destination, Dublin. The capital city of Ireland is the home of the very famous Irish dry stout, Trinity College (plus its stunning library) and a nearly 900-year-old cathedral. It is […]

November 20, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 19 Nov 2015

Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?

French Servier and Pfizer have already had independent partnerships with Cellectis on various R&D areas. But now the two have signed a joint partnership on Cellectis’s leading product UCART19 for blood cancer. This unusual move only further feeds the rumours of Pfizer’s potential future acquisition of Cellectis. As we’ve discussed before, Cellectis has moved most […]

November 19, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 19 Nov 2015

“The Next Generation of Biologicals will be Cell-based”

That’s what Zami Aberman, CEO of one of the world-leading cell-therapy company Pluristem told me during our lunch at Berlin this week. An enthusiastic statement for a sector that could indeed be the next blockbuster after the monoclonal antibodies. Pluristem is an Israel based Biotech company developing off-the-shelf cell therapies for a variety of human diseases. What makes […]

November 19, 2015 - 6 minutesmins - By Philip Hemme

News and Trends 19 Nov 2015

This 10,000 Employee French Pharma is Finally Entering the Biotech Partnership Race

Biotech is getting more and more about partnering rather than doing everything alone. Some conservative Pharmas, which worked to more of a ‘Silo model’, are now branching out in a more open approach; the last one being the Pharma company from the south-west of France Pierre Fabre. The company, named after its iconic founder Pierre Fabre, […]

November 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 18 Nov 2015

Biotech ‘al dente’ – Italy Inaugurates its First Biotech Accelerator

Sofinnova Partners, one of the leading European venture capital firms has helped launch the country’s first ever Biotech accelerator – BiovelocITA. This brand new enterprise intends to boost the Italian biotech market to boom to the same degree it has in countries like Germany and France. Milan launches BiovelocITA, the first Italian accelerator dedicated to […]

November 18, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 18 Nov 2015

The UK Catapults Cell Therapy Manufacture into Europe with a €78.5M New Facility

The UK Government’s Innovate has invested over €78.5M into a new Cell-therapy manufacturing facility for the major UK biotech Catapult Cell Therapy to be located in the growing Biotech cluster in Stevenage. Catapult is a big deal in the UK Biotech scene (apparently) and their division in Cell therapeutics founded in 2012 already has a […]

November 18, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 18 Nov 2015

Nanomedicine Inside Out: A Nestlé Advance in Cuboid Drug Delivery Systems

A New feat in Nanomedicine: The Cubosome drug delivery system has now been 3D-mappped and studied internally by Scientists from the Swiss Federal Institute of Technology (EPFL) and University of Coimbra (Portugal) at the Nestlé Research Center in Lausanne (Switzerland). What are Cubosomes? These small nanostructures are ‘crystalline liquid phases’ engineered in bulk to hold […]

November 18, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 17 Nov 2015

What will Happen now the Microbiome Hype has Broken into the Immuno-Oncology Field?

The Microbiome and Immuno-Oncology fields are hugely trendy in the Biotech Industry – and now a marriage between the two has finally occurred… The Microbiome field is still very new, with the launch of the US Human Microbiome Project just happening in 2008. Nonetheless, some start-ups are moving fast up the microbiome ranks, as well […]

November 17, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 17 Nov 2015

Epigenetics Drug Discovery has a New Champion!

Last week at BIO-Europe 2015 in Munich, I had the opportunity to meet Torsten Hoffmann, CSO of Proteros who told me more about the recent incursion of his company in the Epigenetics space! Proteros is a leader of the Structural Biology field. So, what is this field exactly? Usually, when a Pharmaceutical company is looking […]

November 17, 2015 - 4 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

What happened this week? Genfit, History of Biotech, Cellectis

Get to Know the Top 50 Women in the UK’s Biotech Scene

Cinfa Biotech’s Biosimilar is on the Starting Block!

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?

“The Next Generation of Biologicals will be Cell-based”

This 10,000 Employee French Pharma is Finally Entering the Biotech Partnership Race

Biotech ‘al dente’ – Italy Inaugurates its First Biotech Accelerator

The UK Catapults Cell Therapy Manufacture into Europe with a €78.5M New Facility

Nanomedicine Inside Out: A Nestlé Advance in Cuboid Drug Delivery Systems

What will Happen now the Microbiome Hype has Broken into the Immuno-Oncology Field?

Epigenetics Drug Discovery has a New Champion!

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!